pDONR223-RPS6KB1 Citations (2)
Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal
Articles Citing pDONR223-RPS6KB1
| Articles |
|---|
| Dual PI3K/mTOR Inhibitor, XL765, suppresses glioblastoma growth by inducing ER stress-dependent apoptosis. Zhao H, Chen G, Liang H. Onco Targets Ther. 2019 Jul 8;12:5415-5424. doi: 10.2147/OTT.S210128. eCollection 2019. PubMed |
| N-terminal variant Asp14Asn of the human p70 S6 Kinase 1 enhances translational signaling causing different effects in developing and mature neuronal cells. Venkatasubramani JP, Subramanyam P, Pal R, Reddy BK, Srinivasan DJ, Chattarji S, Iossifov I, Klann E, Bhattacharya A. Neurobiol Learn Mem. 2020 May;171:107203. doi: 10.1016/j.nlm.2020.107203. Epub 2020 Mar 5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.